347 related articles for article (PubMed ID: 14981114)
1. Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes.
Xie P; Hostager BS; Bishop GA
J Exp Med; 2004 Mar; 199(5):661-71. PubMed ID: 14981114
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
3. TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1.
Ardila-Osorio H; Pioche-Durieu C; Puvion-Dutilleul F; Clausse B; Wiels J; Miller W; Raab-Traub N; Busson P
Int J Cancer; 2005 Jan; 113(2):267-75. PubMed ID: 15386359
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
Kilger E; Kieser A; Baumann M; Hammerschmidt W
EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
[TBL] [Abstract][Full Text] [Related]
5. Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1.
Xie P; Bishop GA
J Immunol; 2004 Nov; 173(9):5546-55. PubMed ID: 15494504
[TBL] [Abstract][Full Text] [Related]
6. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
7. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.
Graham JP; Moore CR; Bishop GA
J Immunol; 2009 Sep; 183(5):2966-73. PubMed ID: 19667091
[TBL] [Abstract][Full Text] [Related]
8. LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.
Wu S; Xie P; Welsh K; Li C; Ni CZ; Zhu X; Reed JC; Satterthwait AC; Bishop GA; Ely KR
J Biol Chem; 2005 Sep; 280(39):33620-6. PubMed ID: 16009714
[TBL] [Abstract][Full Text] [Related]
9. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).
Brown KD; Hostager BS; Bishop GA
J Exp Med; 2001 Apr; 193(8):943-54. PubMed ID: 11304555
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.
Hostager BS; Bishop GA
J Immunol; 1999 Jun; 162(11):6307-11. PubMed ID: 10352240
[TBL] [Abstract][Full Text] [Related]
11. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
Grammer AC; Swantek JL; McFarland RD; Miura Y; Geppert T; Lipsky PE
J Immunol; 1998 Aug; 161(3):1183-93. PubMed ID: 9686578
[TBL] [Abstract][Full Text] [Related]
12. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
Eliopoulos AG; Dawson CW; Mosialos G; Floettmann JE; Rowe M; Armitage RJ; Dawson J; Zapata JM; Kerr DJ; Wakelam MJ; Reed JC; Kieff E; Young LS
Oncogene; 1996 Nov; 13(10):2243-54. PubMed ID: 8950992
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.
Kaye KM; Devergne O; Harada JN; Izumi KM; Yalamanchili R; Kieff E; Mosialos G
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11085-90. PubMed ID: 8855313
[TBL] [Abstract][Full Text] [Related]
14. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
15. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.
Busch LK; Bishop GA
J Immunol; 2001 Nov; 167(10):5805-13. PubMed ID: 11698454
[TBL] [Abstract][Full Text] [Related]
16. Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.
Miller WE; Cheshire JL; Raab-Traub N
Mol Cell Biol; 1998 May; 18(5):2835-44. PubMed ID: 9566902
[TBL] [Abstract][Full Text] [Related]
17. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
18. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
Miller WE; Mosialos G; Kieff E; Raab-Traub N
J Virol; 1997 Jan; 71(1):586-94. PubMed ID: 8985387
[TBL] [Abstract][Full Text] [Related]
20. LMP1 TRAFficking activates growth and survival pathways.
Soni V; Cahir-McFarland E; Kieff E
Adv Exp Med Biol; 2007; 597():173-87. PubMed ID: 17633026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
